Ellen Chiniara's Net Worth
$6.15 Million
Who is Ellen Chiniara?
Ellen Chiniara has an estimated net worth of $6.15 Million. This is based on reported shares across multiple companies, which include Compass Therapeutics, Inc., ALEXION PHARMACEUTICALS INC, Kymera Therapeutics, Inc., and ALERE INC..
SEC CIK
Ellen Chiniara's CIK is 0001398764
Past Insider Trading and Trends
2016 was Ellen Chiniara's most active year for acquiring shares with 7 total transactions. Ellen Chiniara's most active month to acquire stocks was the month of January. 2017 was Ellen Chiniara's most active year for disposing of shares, totalling 16 transactions. Ellen Chiniara's most active month to dispose stocks was the month of September. 2016 saw Ellen Chiniara paying a total of $943,500.00 for 60,873 shares, this is the most they've acquired in one year. In 2020 Ellen Chiniara cashed out on 21,176 shares for a total of $3,259,809.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Compass Therapeutics, Inc. (CMPX) Snapshot price: $1.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS, INC. No price found
EVP & Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -116.85K |
—
|
—
|
0
|
Jul 21
| |||
Form 4
| +87.32% | 54.47K |
—
|
—
| 116.85K |
Jul 14
| |||
Form 4
| +44.87% | 19.32K |
—
|
—
| 62.38K |
Feb 28
| |||
Form 4
| +72.57% | 18.11K |
$126.75 | -$3,140,107.80 | 43.06K |
Dec 15 - Dec 16
| |||
Form 4
| +56.33% | 8.99K |
$92.20 | -$109,283.58 | 24.95K |
Dec 15 - Mar 2
| |||
Form 4
| +106.99% | 8.25K |
—
|
—
| 15.96K |
Feb 28
| |||
Form 4
| -7.59% | -633.00 |
$132.92 | -$84,138.36 | 7.71K |
Feb 28
| |||
Form 4
|
∞
| 8.34K |
—
|
—
| 8.34K |
Feb 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kymera Therapeutics, Inc. (KYMR) Snapshot price: $45.4
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +63.60% | 21.75K |
—
|
—
| 55.96K |
Mar 1
| |||
Form 4
| -8.79% | -3.29K |
$22.58 | -$74,415.60 | 34.2K |
Jan 4
| |||
Form 4
|
∞
| 37.5K |
—
|
—
| 37.5K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALERE INC. No price found
GC, Chief Ethics Officer&Sec
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -32.76K |
—
|
—
|
0
|
Oct 3
| |||
Form 4
| +15.94% | 4.5K |
$49.46 | -$106,981.98 | 32.76K |
Aug 31
| |||
Form 4
| +29.83% | 6.49K |
$40.40 | -$131,017.20 | 28.26K |
Feb 16
| |||
Form 4
| +39.62% | 6.11K |
$40.35 | $132,131.55 | 21.53K |
Oct 14
| |||
Form 4
| +76.17% | 6.67K |
—
|
—
| 15.42K |
Sep 9
| |||
Form 4
| +2.72% | 232 |
$33.23 | $7,708.55 | 8.75K |
Dec 31 - Feb 16
| |||
Form 4
| +127.17% | 4.77K |
$41.91 | -$112,567.02 | 8.52K |
Jun 30 - Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||